123 related articles for article (PubMed ID: 2119530)
1. Influence of metoprolol treatment on sympatho-adrenal activation of fibrinolysis.
Larsson PT; Wiman B; Olsson G; Angelin B; Hjemdahl P
Thromb Haemost; 1990 Jun; 63(3):482-7. PubMed ID: 2119530
[TBL] [Abstract][Full Text] [Related]
2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
3. Effects of metformin and metoprolol CR on hormones and fibrinolytic variables during a hyperinsulinemic, euglycemic clamp in man.
Landin K; Tengborn L; Smith U
Thromb Haemost; 1994 Jun; 71(6):783-7. PubMed ID: 7974348
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human erythropoietin on fibrinolytic system in children on continuous ambulatory peritoneal dialysis.
Gündüz Z; Kisaarslan FA; Düsünsel R; Poyrazoglu HM; Saraymen R; Per H
Adv Perit Dial; 1999; 15():278-82. PubMed ID: 10682118
[TBL] [Abstract][Full Text] [Related]
5. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
8. [Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].
Köhler M; Miyashita C
Klin Wochenschr; 1988; 66 Suppl 12():62-7. PubMed ID: 3126347
[TBL] [Abstract][Full Text] [Related]
9. Changes of plasma coagulation and fibrinolysis in response to mental stress.
Jern C; Eriksson E; Tengborn L; Risberg B; Wadenvik H; Jern S
Thromb Haemost; 1989 Sep; 62(2):767-71. PubMed ID: 2814924
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
[TBL] [Abstract][Full Text] [Related]
11. [Effect of molsidomine on fibrinolytic activity: a double-blind, randomized study].
Darius H; Grodzinska L; Hafner G; Meyer J
Z Kardiol; 1991; 80 Suppl 5():47-50. PubMed ID: 1776335
[TBL] [Abstract][Full Text] [Related]
12. Studies of sympatho-adrenal reactivity and adrenoceptor function in bronchial asthma.
Larsson K
Eur J Respir Dis Suppl; 1985; 141():1-52. PubMed ID: 3858102
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of stress reactions during oral surgery after pindolol and metoprolol.
Brisse B; Tetsch P; Schwill E; Bender F
J Pharmacol; 1983; 14 Suppl 2():21-9. PubMed ID: 6314054
[TBL] [Abstract][Full Text] [Related]
15. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N
Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin.
Segal HC; Hunt BJ; Cottam S; Downing A; Beard C; Francis JL; Potter D; Tan KC
Transplantation; 1994 Dec; 58(12):1356-60. PubMed ID: 7528949
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
18. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
Christensen M; Ibsen H; Worck R
Clin Sci (Lond); 2005 Feb; 108(2):113-9. PubMed ID: 15383007
[TBL] [Abstract][Full Text] [Related]
19. Differentiated sympathetic activation during mental stress evoked by the Stroop test.
Hjemdahl P; Freyschuss U; Juhlin-Dannfelt A; Linde B
Acta Physiol Scand Suppl; 1984; 527():25-9. PubMed ID: 6589948
[TBL] [Abstract][Full Text] [Related]
20. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma.
Sørensen JV
Blood Coagul Fibrinolysis; 1994 Feb; 5(1):43-9. PubMed ID: 7514044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
